Filing Flows › National Healthcare (NHC) › Guidance & outlook
National Healthcare (NHC) guidance and outlook
National Healthcare's 10-Q filed Nov 5, 2026 makes 5 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 5, 2026
- We estimate the resulting increase in revenue for the 2027 fiscal year will be approximately $2,000,000 annually, or $500,000 per quarter.
- We estimate the resulting increase in revenue for the 2027 fiscal year will be approximately $7,000,000 annually, or $1,750,000 per quarter.
- We expect to meet our short-term liquidity requirements primarily from our cash flows from operating activities.
- We expect to meet our long-term liquidity requirements primarily from our cash flows from operating activities, our current cash on hand of $66,795,000, our unrestricted marketable equity securities of $154,530,000, and our borrowing capacity on our available line of credit.
- Our future performance will be affected by business, economic, financial and other factors, including potential changes in state and federal government payment rates for healthcare, customer demand, success of our marketing efforts, pressures from competitors, and the state of the economy, including the state of financial and credit markets, as well as many unforeseen factors.
National Healthcare's latest quarter
National Healthcare, Q3 2026: revenue $408M (+7% year over year), operating margin 10.0%, net earnings $13.6M, operating cash flow $99.2M. The chart follows the revenue to costs, profit and cash.
Questions
What does National Healthcare expect?
We estimate the resulting increase in revenue for the 2027 fiscal year will be approximately $2,000,000 annually, or $500,000 per quarter. We estimate the resulting increase in revenue for the 2027 fiscal year will be approximately $7,000,000 annually, or $1,750,000 per quarter. We expect to meet our short-term liquidity requirements primarily from our cash flows from operating activities.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.